People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cerus Endovascular Ltd | — | Biotechnology | Series A | $8.3M | $213.7M | 2017 |
| Arista Therapeutics Inc | — | Other Health Care | Pre-Seed | $300K | $9.2M | 2009 |
J. Todd Derbin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside J. Todd Derbin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Franklin Berger | 1 | 7 |
| PAUL A. BROOKE | 1 | 2 |
| David Jennings | 1 | 2 |
| Stephen J. Griffin | 1 | 2 |
| Sam J. Milstein | 1 | 1 |
| John J. Kilcoyne | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.